Arrowstreet Capital
BMEA icon

Arrowstreet Capital’s Biomea Fusion BMEA Stock Holding History

Arrowstreet Capital’s Portfolio BMEA Stock Details BMEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$605K Buy
+454,616
New +$664K ﹤0.01% 1640

Other funds holding BMEA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Aisling Capital Management
Aisling Capital Management New York $299M AUM 39.78% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $100B AUM 26.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Arrowstreet Capital's BMEA Position: Q3 2026 in Review

Arrowstreet Capital opened a new position in Biomea Fusion (BMEA) in Q3 2026: 454,616 shares worth $605K. The stake represents ﹤0.01% of the portfolio and ranks #1640 among its holdings.

46 funds tracked by Wall St. Rank hold BMEA as of Q3 2026.

  • Arrowstreet Capital held 454,616 shares of Biomea Fusion worth $605K as of Q3 2026.
  • Biomea Fusion was a new Arrowstreet Capital position in Q3 2026.
  • Biomea Fusion made up ﹤0.01% of Arrowstreet Capital's portfolio in Q3 2026, its #1640 holding.
  • 46 funds tracked by Wall St. Rank held Biomea Fusion as of Q3 2026.

Based on Arrowstreet Capital's 13F filing for Q3 2026, filed 13 Nov 2026.